Doctors object to companies offering to store cord bloodBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7323.1203a (Published 24 November 2001) Cite this as: BMJ 2001;323:1203
- Zosia Kmietowicz
Doctors in Britain have criticised companies for persuading expectant parents to part with up to £700 ($980) to have blood collected from their newborn baby's umbilical cord to protect against future illnesses when little evidence exists to support the practice.
The possible uses of stem cells from umbilical blood are so limited that the chance of ever needing them is remote for most families, said advisers from the Royal College of Obstetricians and Gynaecologists. They accuse companies of exploiting pregnant women by offering them a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial